desvenlafaxine

Generic: desvenlafaxine

Labeler: alembic pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name desvenlafaxine
Generic Name desvenlafaxine
Labeler alembic pharmaceuticals limited
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

desvenlafaxine 100 mg/1

Manufacturer
Alembic Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 46708-153
Product ID 46708-153_6ebe192e-2b88-43fc-a2c8-db2c42bc5a43
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA204150
Listing Expiration 2026-12-31
Marketing Start 2013-03-05

Pharmacologic Class

Established (EPC)
serotonin and norepinephrine reuptake inhibitor [epc]
Mechanism of Action
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] cytochrome p450 2d6 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 46708153
Hyphenated Format 46708-153

Supplemental Identifiers

RxCUI
790264 790288
UPC
0346708152307 0346708153304
UNII
NG99554ANW
NUI
N0000000102 N0000175749 N0000000109 N0000182137

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name desvenlafaxine (source: ndc)
Generic Name desvenlafaxine (source: ndc)
Application Number NDA204150 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-153-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-153-90)
source: ndc

Packages (2)

46708-153-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-153-30) 46708-153-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-153-90)

Ingredients (1)

desvenlafaxine (100 mg/1)

Linked Drug Pages (1)

Desvenlafaxine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6ebe192e-2b88-43fc-a2c8-db2c42bc5a43", "openfda": {"nui": ["N0000000102", "N0000175749", "N0000000109", "N0000182137"], "upc": ["0346708152307", "0346708153304"], "unii": ["NG99554ANW"], "rxcui": ["790264", "790288"], "spl_set_id": ["9f74708c-6f6a-46cf-8c79-87a25c2bb6f8"], "pharm_class_epc": ["Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "pharm_class_moa": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-153-30)", "package_ndc": "46708-153-30", "marketing_start_date": "20130305"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-153-90)", "package_ndc": "46708-153-90", "marketing_start_date": "20130305"}], "brand_name": "Desvenlafaxine", "product_id": "46708-153_6ebe192e-2b88-43fc-a2c8-db2c42bc5a43", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "46708-153", "generic_name": "Desvenlafaxine", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Desvenlafaxine", "active_ingredients": [{"name": "DESVENLAFAXINE", "strength": "100 mg/1"}], "application_number": "NDA204150", "marketing_category": "NDA", "marketing_start_date": "20130305", "listing_expiration_date": "20261231"}